Clinical utility of Plasma ctDNA sequencing in metastatic urothelial cancer

Genomic stratification may help improve the management of patients with metastatic urothelial cancer (mUC), given the recent identification of targetable alterations. However, the collection of tissue samples remains challenging. Here, we assessed the clinical utility of plasma circulating tumor DNA (ctDNA) sequencing in these patients.

Source: European Journal of Cancer - October 6, 2023 Category: Cancer & Oncology Authors: C. Helal, C. Pobel, A. Bayle, D. Vasseur, C. Nicotra, F. Blanc-Durand, N. Naoun, A. Bernard-Tessier, A. Patrikidou, E. Colomba, R. Flippot, A. Fuerea, N. Auger, M. Ngo Camus, B. Besse, L. Lacroix, E. Rouleau, S. Ponce, A. Italiano, Y. Loriot Source Type: research